| NCT ID | NCT05037370 |
| Status | Recruiting |
| Phase | — |
| Sponsor | 59th Medical Wing |
| Condition | Refractive Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2021-04-22 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2021-04-22 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective randomized contralateral double-masked study. Each patient will be randomized as to which eye undergoes wave-front optimized (WFO) vs. wave-front guided (WFG) during Photorefractive keratectomy (PRK) or Laser-assisted in situ Keratomileusis (LASIK) surgery to determine which ablation profile provides the best visual outcome.
Eligibility Criteria
Inclusion Criteria: * Meet requirements for PRK or LASIK i.e., Stable \<= .5 D change MRSE) * DOD beneficiaries age 21-50 years * Local pts (w/i 60 mi) who will be in the area for at least 6 months post surgery * Willing to complete all required follow-up visits Exclusion Criteria: * No meeting requirements for PRK or LASIK * Desiring monovision treatment * Anisometropia \>2D spherical equivalent * Prior ocular surgeries / trauma / problem * History of dry eyes * Hyperopia * Mixed astigmatism * Inability to capture VARIO topolyzer scans * Pregnant (or who plans to be within 6 months after surgery) * Breastfeeding any time during the study * History of herpetic disease
Contact & Investigator
CHARISMA B EVANGELISTA, MD
PRINCIPAL INVESTIGATOR
59th Medical Wing
Frequently Asked Questions
Who can join the NCT05037370 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 50 Years, studying Refractive Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05037370 currently recruiting?
Yes, NCT05037370 is actively recruiting participants. Contact the research team at Jose.E.CapoAponte.ctr@health.mil for enrollment information.
Where is the NCT05037370 trial being conducted?
This trial is being conducted at San Antonio, United States.
Who is sponsoring the NCT05037370 clinical trial?
NCT05037370 is sponsored by 59th Medical Wing. The principal investigator is CHARISMA B EVANGELISTA, MD at 59th Medical Wing. The trial plans to enroll 400 participants.